Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| EQL Pharma AB | 2,500 | net | 25 Nov 2020 | tx 1+2,500 |
| Phase Holographic Imaging AB | 1,260 | net | 24 May 2019 | tx 2+1,260 |
| Probi BTA | 500 | net | 29 Mar 2017 | tx 2+500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 25 Nov 2020 | PURCHASE | EQL Pharma AB | 2,500 | 27.40 SEK | first after silence |
| 24 May 2019 | PURCHASE | Phase Holographic Imaging AB | 630 | 28.20 SEK | deriv |
| 20 Jul 2018 | PURCHASE | Phase Holographic Imaging AB | 630 | 71.40 SEK | first after silence |
| 29 Mar 2017 | PURCHASE | Probi BTA | 250 | 420.00 SEK | |
| 24 Oct 2016 | PURCHASE | Probi BTA | 250 | 264.00 SEK |
2 purchases reported after at least 12 months of silence — most recent on 25 Nov 2020.